The 2023 SNQ (Symbol of National Quality) Certification Ceremony was held on December 19th at the Grand Mayfull Hotel in Taipei, Taiwan.

SunWay Biotech, a leading manufacturer of health and nutritional ingredients, boasts its flagship product ANKASCIN® 568-R, the only red yeast rice extract in the global market that does not contain “Monacolin K”. This product was developed by Professor Zi-Ming Pan and his professional R&D team over many years. Known as “NIANJIA Monascus Capsule”, this well-known health product is credited with regulating blood sugar, blood lipids, and anti-aging. Today, it was awarded the 2023 SNQ National Quality Mark Certificate, receiving certification in the category of nutritional health care/special functional health care ingredients.

This certification represents another national-level recognition for SunWay Biotech and its “NIANJIA Monascus Capsule” product, following its achievement at the NutraIngredients Asia Awards – the ‘Oscars’ of health products – held in Singapore in September this year.

The SNQ National Quality Mark, which also symbolizes “Safety and Quality”, communicates the goal of pursuing a healthy life and high-quality living. It aligns with SunWay Biotech’s corporate philosophy of “Quality First, Health Priority, Customer Foremost” and NIANJIA’s principle of “The Best for Protecting What We Love Most.”.

Each year, the SNQ is based on an extremely strict review system and standard requirements, with “scientific evidence” at its core. The goal is to maintain product quality and public health through annual reviews. This certification indicates that the quality and safety of SunWay Biotech’s ANKASCIN® 568-R patented red yeast rice ingredient is recognized by authoritative experts in the field and verified by third-party impartial entities.

Differing from traditional red yeast rice products, SunWay Biotech’s ANKASCIN® 568-R is the only red yeast rice extract in the global market without “Monacolin K”. Since Monacolin K shares a chemical structure with cholesterol-lowering Statin drugs, it not only lowers cholesterol through the same mechanism but also metabolizes in the same way, possibly leading to food-drug interactions. Hence, many advanced countries have set upper limits on the content of “Monacolin K” in red yeast rice extracts in health foods. The United States, in particular, has established a policy of zero detection, prohibiting any “Monacolin K” in red yeast rice products categorized as dietary supplements/nutritional health products. This has made SunWay Biotech the only manufacturer able to supply red yeast rice extract materials for the U.S. market.

With the SNQ National Quality Mark certification, not only are customers and markets that are skeptical of traditional red yeast rice more inclined to use SunWay Biotech’s patented red yeast rice ingredients, but it also fosters a willingness for strategic cooperation and the expansion into new products and markets, opening up international opportunities.